We have an established partnering model with Hikma, for our programmes to develop generic versions of GSK's Ellipta® portfolio and Advair Diskus®, and with Sandoz.

For customers utilising our product development expertise, we provide quality services in changing scientific and operational environments. We’re focused on helping customers to achieve their ambitions, bringing their medicines to market and overcoming development and formulation challenges.

How we engage

We maintain close working relationships with our customers and partners, ensuring regular feedback and dialogue so that we deliver consistent, reliable and high-quality services to meet their needs and expectations.

We continue to invest in our people, our IP and our core capabilities and technologies, placing Vectura as a unique partner within the industry.